Boston Clinical Trials ( Site 1028) — Boston, Massachusetts

Boston Clinical Trials ( Site 1028) is a clinical research site located in Boston, Massachusetts, United States 02131.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Boston Clinical Trials ( Site 1028) has participated in 1 clinical trials.

Therapeutic areas: Treatment Resistant Depression.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Clinical Trials ( Site 1028)?

Boston Clinical Trials ( Site 1028) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Clinical Trials ( Site 1028) conducted?

Boston Clinical Trials ( Site 1028) has 1 clinical trials on record. Their work covers Treatment Resistant Depression.

Is Boston Clinical Trials ( Site 1028) accredited by Crixeo Health?

Boston Clinical Trials ( Site 1028) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Clinical Trials ( Site 1028)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.